Intra Cellular Therapies shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Assenagon Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $45M | 650k | 69.20 |
| 2023-12-31 | $55M | 764k | 71.62 |
| 2023-09-30 | $26M | 489k | 52.09 |
| 2023-06-30 | $12M | 190k | 63.32 |
| 2023-03-31 | $7.2M | 133k | 54.15 |
| 2022-12-31 | $4.2M | 80k | 52.92 |
| 2022-09-30 | $2.2M | 47k | 46.54 |
| 2022-06-30 | $2.2M | 39k | 57.08 |
| 2022-03-31 | $5.7M | 93k | 61.19 |
| 2021-12-31 | $6.7M | 128k | 52.34 |
| 2021-03-31 | $7.1M | 208k | 33.93 |
| 2020-12-31 | $6.5M | 204k | 31.80 |
| 2020-09-30 | $12M | 476k | 25.66 |
| 2020-06-30 | $6.8M | 267k | 25.67 |
| 2020-03-31 | $2.2M | 146k | 15.37 |
| 2019-12-31 | $650k | 19k | 34.31 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management